`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`
`MYLAN PHARMACEUTICALS INC.,
`MSN LABORATORIES PRIVATE LTD.,
`and MSN PHARMACEUTICALS INC.,
`
`Petitioner,
`
`v.
`
`BAUSCH HEALTH IRELAND LIMITED,
`
`Patent Owner.
`
`__________________
`
`Case IPR2022-007221
`U.S. Patent No. 7,041,786
`__________________
`
`PATENT OWNER’S REQUEST FOR ORAL HEARING
`
`
`
`
`1 IPR2023-00016 has been joined with this proceeding.
`
`
`
`
`
`
`
`The Board tentatively scheduled oral hearing for this proceeding for June 14,
`
`2023. Paper 17 at 12 (DUE DATE 8). Pursuant to 37 C.F.R. § 42.70(a), Patent
`
`Owner Bausch Health Ireland Limited requests oral hearing on all instituted grounds
`
`of unpatentability for claims 1-6 of U.S. Patent No. 7,041,786, any motion to exclude
`
`filed by either party, and any other issues that may affect the Board’s determination
`
`in this proceeding. Patent Owner also requests hearing on any issues specified by
`
`Petitioner in its Request for Oral Argument and any issues that the Board deems
`
`necessary for issuing a final written decision.
`
`Patent Owner requests that it and Petitioner each be allotted 60 minutes of
`
`argument time. To the extent the Board schedules the hearing to last less than or
`
`more than 120 minutes of total argument time, however, Patent Owner requests that
`
`it be allotted half the length of the hearing.
`
`Patent Owner requests that the panel hear oral argument virtually by remote
`
`means. To the extent the panel prefers to hold oral argument by in-person hearing
`
`at the San Jose, California, USPTO Regional Office, Patent Owner requests that two
`
`spaces be reserved for counsel at counsel’s table and that three additional spaces be
`
`reserved in the hearing room to accommodate additional counsel and/or corporate
`
`representatives, and Patent Owner requests the ability to use computers and
`
`audio/visual equipment to display demonstrative exhibits and evidence, including
`
`the use of a projector and screen.
`
`
`
`
`
`
`
`
`
`Date: May 3, 2023
`
`Case No. IPR2022-00722
`U.S. Patent No. 7,041,786
`
`Respectfully submitted,
`
`
`
`
`/Justin J. Hasford/
`By:
`Justin J. Hasford, Reg. No. 62,180
`Lead Counsel
`Bryan C. Diner, Reg. No. 32,409
`Back-up Counsel
`Joshua L. Goldberg, Reg. No. 59,369
`Back-up Counsel
`Kassandra M. Officer Reg. No. 74,083
`Back-up Counsel
`Lauren J. Robinson Reg. No. 74,100
`Back-up Counsel
`Caitlin E. O’Connell, Reg. No. 73,934
`Back-up Counsel
`Kyu Yun Kim, Reg. No. 72,783
`Back-up Counsel
`
`Finnegan, Henderson, Farabow,
` Garrett & Dunner, LLP
`
`Counsel for the Patent Owner
`
`
`
`2
`
`
`
`
`
`Case No. IPR2022-00722
`U.S. Patent No. 7,041,786
`
`CERTIFICATE OF SERVICE
`The undersigned hereby certifies that a copy of the foregoing Patent Owner’s
`
`Request for Oral Hearing was served electronically via email on May 3, 2023 to
`
`counsel of record for the Petitioner at the following:
`
`Jad A. Mills
`Wilson Sonsini Goodrich & Rosati PC
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`jmills@wsgr.com
`
`Richard Torczon
`Tasha M. Thomas
`Wilson Sonsini Goodrich & Rosati PC
`1700 K Street N.W., 5th Floor
`Washington, DC 20006
`rtorczon@wsgr.com
`tthomas@wsgr.com
`
`
`Dennis D. Gregory
`Wilson Sonsini Goodrich & Rosati PC
`900 South Capital of Texas Highway, Las Cimas IV, Fifth Floor
`Austin, TX 78746-5546
`dgregory@wsgr.com
`
`4863-5899-2145@mail.vault.netdocuments.com
`
`Andrew O. Larsen
`Merchant & Gould, P.C.
`500 Fifth Avenue, Suite 4100
`New York, NY 10110
`alarsen@merchantgould.com
`
`Melissa Hayworth
`Merchant & Gould, P.C.
`
`
`
`
`
`
`
`
`Case No. IPR2022-00722
`U.S. Patent No. 7,041,786
`
`1900 Duke, Street, Suite 600
`Alexandria, VA 22314
`mhayworth@merchantgould.com
`
`Christopher J. Sorenson
`Merchant & Gould, P.C.
`150 South Fifth Street, Suite 2200
`Minneapolis, MN 55402
`csorenson@merchantgould.com
`
`plecanatidemerchant@merchantgould.com
`
`
`
`By: /Geneva Eaddy/
`Geneva Eaddy
`Case Manager
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`
`
`
`
`
`
`
`
`
`Date: May 3, 2023
`
`
`
`
`
`
`